A case of a patient receiving combination therapy with paclitaxel plus bevacizumab and adoptive activated αβ T-cell immunotherapy in advanced breast cancer

Takaaki Masuda; Atsushi Nonami; Fumiaki Tanaka; Yuki Ando; Masatoshi Eto; Koshi Mimori

doi:10.1111/tbj.14108

A case of a patient receiving combination therapy with paclitaxel plus bevacizumab and adoptive activated αβ T-cell immunotherapy in advanced breast cancer

Takaaki Masuda, Atsushi Nonami, Fumiaki Tanaka, Yuki Ando, Masatoshi Eto, Koshi Mimori

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	2420-2423
Number of pages	4
Journal	Breast Journal
Volume	26
Issue number	12
DOIs	https://doi.org/10.1111/tbj.14108
Publication status	Published - Dec 2020

All Science Journal Classification (ASJC) codes

Internal Medicine
Surgery
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/tbj.14108

Cite this

@article{0dbf02e0f6714deb8bc73b07a1327a5c,

title = "A case of a patient receiving combination therapy with paclitaxel plus bevacizumab and adoptive activated αβ T-cell immunotherapy in advanced breast cancer",

author = "Takaaki Masuda and Atsushi Nonami and Fumiaki Tanaka and Yuki Ando and Masatoshi Eto and Koshi Mimori",

note = "Funding Information: This work was supported in part by: Japan Society for Promotion of Science (JSPS) Grant-in-Aid for Science Research (20K17556) and JST AIP-PRISM (JPMJCR18Y5). Funding Information: This work was supported in part by: Japan Society for Promotion of Science (JSPS) Grant‐in‐Aid for Science Research (20K17556) and JST AIP‐PRISM (JPMJCR18Y5). ",

year = "2020",

month = dec,

doi = "10.1111/tbj.14108",

language = "English",

volume = "26",

pages = "2420--2423",

journal = "Breast Journal",

issn = "1075-122X",

publisher = "Wiley-Blackwell",

number = "12",

}

TY - JOUR

T1 - A case of a patient receiving combination therapy with paclitaxel plus bevacizumab and adoptive activated αβ T-cell immunotherapy in advanced breast cancer

AU - Masuda, Takaaki

AU - Nonami, Atsushi

AU - Tanaka, Fumiaki

AU - Ando, Yuki

AU - Eto, Masatoshi

AU - Mimori, Koshi

N1 - Funding Information: This work was supported in part by: Japan Society for Promotion of Science (JSPS) Grant-in-Aid for Science Research (20K17556) and JST AIP-PRISM (JPMJCR18Y5). Funding Information: This work was supported in part by: Japan Society for Promotion of Science (JSPS) Grant‐in‐Aid for Science Research (20K17556) and JST AIP‐PRISM (JPMJCR18Y5).

PY - 2020/12

Y1 - 2020/12

UR - http://www.scopus.com/inward/record.url?scp=85097064049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85097064049&partnerID=8YFLogxK

U2 - 10.1111/tbj.14108

DO - 10.1111/tbj.14108

M3 - Comment/debate

C2 - 33277749

AN - SCOPUS:85097064049

VL - 26

SP - 2420

EP - 2423

JO - Breast Journal

JF - Breast Journal

SN - 1075-122X

IS - 12

ER -

A case of a patient receiving combination therapy with paclitaxel plus bevacizumab and adoptive activated αβ T-cell immunotherapy in advanced breast cancer

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this